Graduate Certificate: Biopharmaceutical Manufacturing and Regulatory Affairs

SCHOOL OF PHARMACY

About the Certificate

The graduate certificate in Biopharmaceutical Manufacturing and Regulatory Affairs is intended to enable Regulatory Affairs and Quality Assurance (RAQA) students to receive formal recognition for studying the highly specialized, rapidly growing field of pharmaceutical biotechnology, which includes the manufacturing techniques and applicable regulations used in the development and production of biotechnology products. The first biopharmaceutical product, namely, recombinant human insulin, was approved in 1982. Since then, products derived through biotechnology have provided advances in medicine that include therapeutic monoclonal  antibodies, cancer vaccines, cytokines, antisense technology, interference RNA, and growth factors. The regulatory framework required for the approval of biotechnology-derived products (or biologics) is lengthy, rigorous, and highly complicated. This certificate delves into the complex regulations governing the development, manufacturing, and distribution of such products.

Through completion of the certificate, whether post-baccalaureate or post-master's, students understand the following:

  • the pharmaceutical science behind the discovery of biotechnology products, including biologics, biosimilars, and biopharmaceuticals;
  • the requirements for sourcing and testing materials used in the production of biotechnology products;
  • the technologies and unique considerations associated with the manufacturing and distribution of biotechnology products;
  • the applicable regulations involved with biotechnology products; and
  • the processes used to sterilize biotechnology products, including regulatory requirements for thermal, gaseous, radiation, filtration, and aseptic processing.

Time Limit for Certificate Completion: 3 years

Campus Location: Fort Washington

Full-Time/Part-Time Status: The graduate certificate may be completed on a part-time basis.

Non-Matriculated Student Policy: Non-matriculated students may take up to 9 credits of coursework before applying to the graduate certificate program.

Admission Requirements and Deadlines

Application Deadline:
Fall and Spring admissions are on a rolling basis. Interested students should contact the School of Pharmacy for permission to enroll in coursework.

Master's Degree in Discipline/Related Discipline: Applicants completing the program to earn a post-master's certificate must hold a master's degree in a Pharmacy-related field.

Bachelor's Degree in Discipline/Related Discipline: Applicants completing the program to earn a post-baccalaureate certificate must hold a B.S. degree in Biochemistry, Biology, Chemistry, Physics, or a health-related discipline.

Certificate Requirements

Number of Credits Required to Complete the Certificate: 15

Required Courses:

Core Courses
QARA 5471Biotechnology: Bioprocess Basics3
QARA 5475Pharmaceutical Biotechnology3
QARA 5515Biologics/Biosimilars: A Regulatory Overview3
QARA 5577Global CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics3
Elective3
Select one from the following:
Production of Sterile Parenterals
Sterilization Processes
QARA 5501
Development of Sterile Products
Microbiological Concepts in Pharmaceutical Manufacturing
Vaccines: Regulatory Affairs and Quality Assurance Issues
Total Credit Hours15

Courses

QARA 5000. Special Topics in Regulatory Affairs and Quality Assurance. 2 to 4 Credit Hours.

Topics vary.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may be repeated for additional credit..

QARA 5401. Fundamentals of Pharmacology and Pharmacokinetics. 3 Credit Hours.

This introductory course to general pharmacology includes discussions of the mechanisms of action of selected drug classes. It covers pharmacokinetics, including clearance, bioavailability, compartment models, extravascular dosing, nonlinear pharmacokinetics and pharmacodynamics as they apply to the drug development process. Note: Not open to students who have taken the former PHARMACEUTICS 400 or those in the Non-Thesis M.S. program who have taken PHARMACEUTICS 5401.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5408. Pharmacoeconomics. 3 Credit Hours.

The economic methodologies used to evaluate the cost effectiveness of drug therapy are reviewed. Cost effectiveness is examined in terms of outcome assessment and quality of life measurements. The course explores the dynamic environment of health care and the process of drug product selection in managed care.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5451. Statistical Quality Control. 3 Credit Hours.

An introduction to statistical concepts, this course reviews control charts for variables, probability theory, control charts for attributes, and acceptance sampling systems. Class discussions include application to quality control of pharmaceutical manufacturing.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5458. Global Biopharmaceutical Industry. 3 Credit Hours.

What social and economic factors contributed to the development of innovator and generic pharmaceutical companies, and what are their current and future trends?  This course introduces students to the basic structure of the pharmaceutical industry, examining the growth and relationships among various sectors, including the fully-integrated companies of big pharma, the generic and biotech industry, and specialty and service companies, such as CROs and CMOs.  Social, political, demographic, economic, and technological influences will be examined not only in the US domestic market, but also across major world economies, including the differences between national health and single-payer systems.  A segment of the course focuses on the impact of the Waxman-Hatch Act on drug price competition and patent term restoration.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5459. Drug Development. 3 Credit Hours.

This course studies the drug development process from discovery through FDA marketing approval. It reviews the process of development and the interrelationships linking the various disciplines, introducing students to regulations governing the process, including the interactions with FDA, ICH, and other regulatory agencies. Note: This course is required for the M.S. in RA and QA, the Drug Development Certificate, and the Certificate in Clinical Trial Management.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5469. Pharmaceutical Laboratory Quality Systems and Operations. 3 Credit Hours.

The laboratory plays a key role in the manufacture and release of pharmaceuticals. An effective QC lab assures the integrity of the data generated to enable the release of raw materials, in-process, and finished products and also meets production schedules. In addition, production-related responsibilities must meet with compliance standards. This course covers these responsibilities in detail while providing insight on how to meet internal and regulatory requirements for lab operations. Why labs fail and what actions must be taken to prevent failure are covered in depth.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5471. Biotechnology: Bioprocess Basics. 3 Credit Hours.

This course emphasizes regulatory and control aspects of biologics manufacturing as well as Quality by Design principles. It provides students with a basic understanding of the major steps involved in the manufacture of biologics/biopharmaceuticals, including preparation of media, fermentation, harvesting/recovery, purification, and formulation. Included is a review of basic bioscience topics (e.g., microbiology, biochemistry, and molecular biology) with particular relevance to the study of bioprocessing techniques. Note: Not open to students who have taken the former PHARMACEUTICS 481 or those in the Non-Thesis M.S. program who have taken PHARMACEUTICS 475 or PHARMACEUTICS 5471.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5472. Pharmaceutical Marketing. 3 Credit Hours.

This course describes the marketing dynamics of the healthcare industry and the ways in which pharmaceutical companies can better meet the changing needs of patients and managed care. Focusing on individual marketing techniques, it stresses the development of multidisciplinary marketing teams. The product attributes discussed in the selling process are efficacy, safety, cost effectiveness, compliance, and treatment outcomes.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5473. Generic Drug Regulation (ANDAs). 3 Credit Hours.

By examining specific case studies of Abbreviated New Drug Applications (ANDAs) which document the bioequivalence of generics to an original product, this course gives students an overview of regulatory requirements for generics, introducing problems unique to this segment of the industry.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5474. Process Validation. 3 Credit Hours.

Since the concept of "validation" originally appeared in GMP regulations, it has extended to every step in product manufacturing from building the plant to the methods used for testing and releasing its products. The course exposes students to all aspects of validation. FDA Guides and Guidelines, as well as the current emphasis on validation concerns by FDA (as identified in 483 and Warning Letter observations), will be incorporated. Students develop acceptable validation protocols and learn what constitutes an acceptable validation report.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5475. Pharmaceutical Biotechnology. 3 Credit Hours.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5476. Good Laboratory Practices. 3 Credit Hours.

This course explores the regulatory and quality assurance issues pertinent to pre-clinical safety research. Research study design and processes will be analyzed by pharmacologic and toxicologic methods and for carcinogenicity and reproductive toxicology. Some time is devoted to mutagenicity and pharmacokinetics, discussed in the context of developing a safety profile and determining the potential risk to humans in subsequent clinical trials. Note: This course fulfills the GxP requirement for M.S. in RA and QA students and for the Drug Development Certificate.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5477. Good Manufacturing Practices. 3 Credit Hours.

This course provides an introduction to cGMP (current good manufacturing practices). Regulations for drugs under the Food, Drug and Cosmetic Act (21 CFR 210 and 211) and their implication for personnel, buildings, equipment, and records will be thoroughly reviewed and studied. It includes a study of pertinent legal decisions and regulatory actions based on non-compliance. Note: This course fulfills the GxP requirement for RA and QA MS students and for the Drug Development Certificate. Students with extensive manufacturing experience in GMPs may petition the School to allow them to replace the basic GMP class with Advanced GMPs. To do so, students must have at least five years of GMP experience and submit a resume to the RA and QA Office for final approval.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5478. High Purity Water Systems. 3 Credit Hours.

This course examines high purity water systems from the Quality Function perspective, covering basic aspects of system design and operation. Special attention is paid to unit operations, sanitization procedures, and routine monitoring programs. Students learn to plan validations and establish routine monitoring programs to assess ongoing quality. Domestic (NFDWR/NSDWR) requirements and international standards and regulatory expectations are discussed.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5479. Advanced Good Manufacturing Practices - Defining "c". 3 Credit Hours.

This course brings students from the basic GMP concepts presented in QARA 5477 to a fuller understanding of the concepts of current good manufacturing practices. Discussions include how to evaluate FDA 483s and Warning Letters, the routine review of periodicals, including the Pink Sheet, Gold Sheet, and other GMP-oriented documents, and how to evaluate information provided by the FDA. Recalls are discussed.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5491. Pre-Approval Inspections. 3 Credit Hours.

This course provides a detailed overview of Pre-Approval Inspections and how to conduct audits of facilities based on the responsibilities delineated in a pending drug application, including NDAs, ANDAs and NADAs. Emphasis is placed on reviewing the Pre-approval audit process, Pre-Approval laboratory issues (including analytical and microbiological), technology transfer, case studies involving various dosage forms, and outsourcing issues. This course stresses key areas for Pre-Approval inspection audits. Case studies help prepare students for issues arising during a Pre-Approval inspection. The history and evolution of the Pre-Approval program are discussed. Note: Not open to students who have taken the former PHARMACEUTICS 490.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5492. Production of Sterile Parenterals. 3 Credit Hours.

This course reviews the theory and practice involved in the preparation of sterile, injectable products, covering formulation, manufacturing, facility requirements, validation and regulatory issues. Upon completion of the course, students will develop an understanding of the routes of administration of injectable drugs and the types of injections, current formulation methods, aseptic manufacturing processes, requirements for sterile manufacturing facilities, and validation, compliance and regulatory issues.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5493. Sterilization Processes. 3 Credit Hours.

A study of the theory and application of sterilization processes in the preparation of sterile pharmaceutical materials. The course provides a mixture of lecture and group discussion covering basic principles and sterilization technology. The course will focus on moist heat sterilization using autoclaves which is the predominant sterilization method employed in the production of pharmaceuticals. A case study will be used in the course demonstrating the specification, installation, qualification and regulatory approval of a new autoclave facility. An overview of gas and radiation sterilization will be provided.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5494. Quality Audit. 3 Credit Hours.

This course covers topics in quality assurance principles, audit techniques, audit types, audit presentation and reports, auditing procedures for GMPs, GCPs, and GLPs. Note: This course is required for the M.S. in RA and QA; however, students interested in RA may substitute IND/NDA Submissions.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5495. Investigational New Drug/New Drug Application Submissions. 3 Credit Hours.

This course covers the development of Investigational New Drug (IND) and New Drug Application (NDA) submissions for FDA review. The major emphasis is directed toward developing an understanding of the philosophies and requirements FDA imposes on data submitted to support INDs and NDAs. It covers the process of producing INDs and NDAs (managing the teams, producing the submission, using electronic media) and emphasizes how to work with FDA to gain approval of a submission. FDA meetings, advisory panel hearings, appeals, strategies for review and approval of NDAs, use of Orphan drug status, and the various avenues of expedited review are discussed. Note: This course is required for the M.S. in RA and QA; however, students interested in QA may substitute Quality Audit.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5496. Regulation of Medical Devices: Compliance. 3 Credit Hours.

This course examines the broad scope of the medical device industry and its quality assurance practices, covering the preclinical, clinical, manufacturing, postmarket reporting, and device-tracking compliance regulations in the U.S. and other major world markets.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5497. Statistics for Clinical Trials. 3 Credit Hours.

Assuming no previous courses in statistics, this introductory course reviews topics of interest in statistical evaluation of clinical trials.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5498. Computer Validation. 3 Credit Hours.

This course focuses on the application of computer validation concepts to computer systems operating within a pharmaceutical research and development environment. It presents the specific needs and responsibilities of the various regulatory requirements and guidelines (both domestic and global).

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5499. Drug Dosage Forms. 3 Credit Hours.

Through an overview of drug dosage form design and manufacturing technology, principles of pharmaceutical processing and pharmaceutical dosage form design (including preformulation and biopharmaceutics) are discussed, including dosage forms such as tablets, capsules, modified dosage forms, semi-solid products, and transdermal delivery systems.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5502. Regulation of Medical Devices: Submissions. 3 Credit Hours.

This course provides an overview of medical device submissions. The course begins with a review of laws specific to medical devices such as the requirement for pre-market submissions. Specific topics include device classification, investigational device exemption (IDE) applications, pre-market notification submissions [510(k)s], pre-market approval applications (PMAs), humanitarian device exemptions (HDEs), product development protocols (PDPs), STED and an overview of Global Harmonization Task Force recommendations.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5503. Design Controls for Medical Devices and Combination Products. 3 Credit Hours.

This course focuses on design control requirements and practices in the medical device and combination products industry. Class discussions will include design control requirements as they apply to medical devices and combination products. Current regulations and practices will be discussed and utilized to provide students with experience in executing design control activities for a range of products.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5505. Global Regulation of Medical Devices. 3 Credit Hours.

This course provides an overview of international medical device regulations. Beginning with a discussion of the similarity of global requirements (including both voluntary and mandatory standards and directives and progressing to in-depth analyses of market specific requirements), the course provides students with resources to meet the regulatory requirements for the largest world markets. The Medical Device Directive, the In Vitro Diagnostic Directive and the Active Implantable Medical Device Directive will be discussed, as well as initiatives by the Global Harmonization Task Force related to the classification, development, and complaint handling for medical devices. As part of this course, the student will learn the quality system requirements of ISO13485, risk management according to ISO14971 and how to CE mark their product. Country-specific regulatory requirements for Canada, EU, Australia and Japan are included.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5506. Environmental Law and Regulation (EPA). 3 Credit Hours.

The mission of the Environmental Protection Agency (EPA) is to protect human health and the environment. This course will provide an understanding of basic environmental laws and regulations and EPA's enforcement activities.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5508. Good Pharmacovigilance Operations. 3 Credit Hours.

This course provides a solid foundation for understanding/managing the complexities of the lifecycle of an individual case safety report (ICSR).  It reviews the process from receipt of the ICSR to reporting to regulatory authorities (both as an expedited ICSR and within a periodic safety update report). It compares US and EU regulations and ICH guidances in this area. It also covers the requirements for a validated safety database to process ICSR and Quality Systems in a Pv department. The course discusses the management of a Pv department and the business decisions required to manage the volume of cases received. Also discussed is the role of Pv agreements and preparation for a Pv inspection.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5511. Advanced Audit Workshop of Quality Systems. 3 Credit Hours.

This course, which is a continuation of Quality Audit, discusses the components of a quality system in greater depth and detail, including control systems, procedures, and documentation. Students design and audit a quality system; they also audit and critique quality systems presented by the faculty member.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5512. Microbiological Concepts in Pharmaceutical Manufacturing. 3 Credit Hours.

This course addresses essential microbiology concepts of manufacturing and quality control that form the basis of Good Manufacturing Practices for both sterile and non-sterile pharmaceuticals. Emphasis is placed on a review of the following from a microbiological perspective: manufacturing technologies and techniques, building quality into processes, influence of raw material quality on finished product, the meaning of the qualification and validation studies conducted by drug firms, and key microbiological tests performed at in-process and finished product stages. The course stresses practical matters and includes case studies to prepare students for daily issues arising in industry.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5513. Active Pharmaceutical Ingredients (APIs). 3 Credit Hours.

This course provides a working background on Active Pharmaceutical Ingredients (APIs) used in pharmaceutical dosage forms with focus on the development, manufacture and global regulations that impact successful marketing approval of products. The primary focus is on small molecule synthetic APIs.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits

Pre-requisites:
QARA 5459|Minimum Grade of B-|May not be taken concurrently.

QARA 5514. Regulatory Electronic Submissions. 3 Credit Hours.

This course explores current regulations, tools, and specifications associated with global regulatory submissions and how these submissions have evolved from original paper formats to the current electronic Common Technical Document (eCTD) and non-eCTD electronic submissions (NeeS). Topics include similarities and differences of regulatory requirements of various global health agencies for formatting, publishing, validating and maintaining security of documents. Discussions include acceptable and required file types for eSubmissions (ranging from safety and pharmacovigiliance reports, clinical studies, annual reports, health authority responses, etc.) and acceptable transition methods of legacy paper submissions to electronic formats. The course includes class discussions and workshops around common eSubmission issues.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5515. Biologics/Biosimilars: A Regulatory Overview. 3 Credit Hours.

Since the first biopharmaceutical product approval in 1982 (recombinant human insulin), the biotechnology derived product market has been rapidly growing with introduction of a number of promising advances in medicine such as therapeutic monoclonal antibodies, cancer vaccines, cytokines, antisense technology, interference RNA, and growth factors.  As with traditional drugs (small molecules), the regulatory framework for approval of a biotechnology derived product (biologics) is complicated.  In addition, there has been much debate about the introduction of biosimilars using an abbreviated approval process.  An overall biologics-based process map beginning with pre-clinical through the post-marketing stage will be discussed.  Topics such as therapeutic proteins/peptides, gene therapy, stem cells, vaccines, interference RNAs, PK-PD, world-wide regulatory filings, pre-clinical IND-enabling studies, BLA/CTD filing, biosimilars/follow-on-biologics, selected case studies, immunogenicity, comparability studies, manufacturing challenges, clinical trials, market exclusivity, and related regulatory guidelines will be discussed.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5516. Cleaning Validation. 3 Credit Hours.

This course will review the different aspects of a pharmaceutical cleaning validation program and the criteria for each. The course will go from protocol to final report with emphasis on the regulatory risks and consequences. FDA and other regulatory agency observations will be highlighted to reinforce class material.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5517. Quant Methods-Benefit/Risk. 3 Credit Hours.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5518. Regulatory Issues in Pharmacogenomics. 3 Credit Hours.

Pharmacogenetics (PGt) is the study of genetic causes of variability in drug metabolism (pharmacokinetics) and responses to drugs, including adverse events (AEs) and desired pharmacological effects (pharmacodynamics).  Variability can be attributed to variations in DNA, such as polymorphisms, or sequences that influence an enzyme or a receptor activity. Pharmacogenomics (PGx) is the science involving pharmacology and genomics which studies how genetic differences within a population affect body's response to a drug.  After the completion of the Human Genome Project, PGx has become an attractive tool in the attempt to develop personalized medicine that can be adapted to each person's own genetic makeup and lead to a higher therapeutic efficacy.  The FDA (and other regulatory agencies) is requesting that sponsors conducting such programs consider providing pharmacogenomic data to the Agency voluntarily, when such data are not otherwise required under the regulations.  Such voluntary submissions would facilitate the drug approval process and help identify patients who need dose adjustments or are prone to certain toxic effects (reflected in the drug's label).

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5532. Global Labeling Regulation: Principles and Practices. 3 Credit Hours.

Provides a detailed analysis of corporate labeling practices in the U.S. and E.U., comparing and contrasting FDA, EU, and International Congress on Harmonization regulations. Special focus is devoted to new FDA guidelines and pharmacovigilance guidelines.

Department restrictions: Must be enrolled in one of the following Departments: Pharmacy:QA/RA
Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5533. Requirements for Product Labeling and Advertising. 3 Credit Hours.

This course examines strategies for creating drug labeling during new product development, for updating existing product labeling, and for creating "harmonized" core data sheets for products marketed globally. Students gain insight and awareness of current trends in advertising and promotional regulation.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5534. Regulatory Aspects of Biomedical/Technical Communication. 3 Credit Hours.

This course reviews regulatory requirements of biomedical/technical writing in the pharmaceutical industry. Students research, summarize, and organize typical scientific data. Issues of content (relevancy, accuracy, balance, and currency), organization, and style (e.g., American medical Association Manual of Style and current FDA and ICH guidelines) are addressed. Writing exercises include topics such as the Physician's Desk Reference, developing product label package inserts, and summarizing studies in pharmacokinetics, pharmacodynamics, efficacy and safety, product development, and stability.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5535. Advanced Topics in Labeling Development. 3 Credit Hours.

This course reviews the regulatory and legal fundamentals of labeling FDA-regulated products, specifically, prescription pharmaceuticals, emphasizing the direct application of the regulations to actual practice. It analyzes case studies and current practices, providing an overview of legal, regulatory, and marketing concepts affecting labeling. It discusses the application of current knowledge and explores new trends in the legal and regulatory framework surrounding the development and implementation of drug labeling. As a class project, students are assigned to drug development teams (Regulatory Affairs, Marketing and Clinical) and provided with the known data of their compounds. Teams determine what information is needed to complete the draft labeling for NDA submission, and develop a final label; they hold mock negotiations (internal and with the Agency) and propose changes to labeling in response to post-marketing surveillance.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5536. Good Clinical Practices. 3 Credit Hours.

This course examines the federal regulatory requirements and processes necessary to conduct valid drug trials on human volunteers. Emphasis is placed on managing the clinical drug study and auditing its processes and generated data. The course also addresses ethical issues and volunteer informed consent. Note: This course fulfills the GxP requirement for the M.S. in RA and QA students and for the Drug Development Certificate. It is required for the Certificate in Clinical Trial Management.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5537. Clinical Trial Management. 3 Credit Hours.

This course is designed to help the clinical research department member and those familiar with the industry working in related fields become more effective members of the clinical research team, whether at a company or an investigator's office. This course covers the day-to-day operations of a clinical trial, from site and investigator selection through monitoring and data retrieval. It covers key topics such as budgeting, protocol preparation, site and investigator selection, monitoring, document and file creation and maintenance, and the participation of key members of the principal investigator's team. Note: This course is required for the Certificate in Clinical Trial Management.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5538. Clinical Drug Safety and Pharmacovigilance. 3 Credit Hours.

This course provides students with an in-depth understanding of what pre-marketing Clinical Safety and Risk Management (CSRM) means in the context of both American (FDA) and international (ICH-E2C) regulatory requirements. Beginning with an historical overview of IND and international safety requirements, it examines the processes and systems in place to support compliance and the strategic documentation required for applications. It also looks at the role of risk management and epidemiological methods used to identify the signals used to quantify, assess, and communicate adverse drug reactions (ADR). Topics include clinical trial policy, the roles of the investigator, patient, and IRBs, privacy issues, informed consent, DSMB, and other related matters. Note: This course may be substituted in place of Clinical Data Management in the Certificate in Clinical Trial Management.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5539. Global Clinical Drug Development. 3 Credit Hours.

This course focuses on the specific regulatory requirements of clinical development in the European Union, Easter Europe, Latin America, Canada, India, China and Japan. It will review the efforts of the International Conference on Harmonization (ICH) to unify Good Clinical Practices (GCPs) in these global areas, exploring the differences between cultures, races, and societies and the impact of socialized medicine. Upon successful completion of this course, students will: gain an overview of multinational clinical drug development; gain a basic understanding of cultural differences towards GCPs in various regions of the world; understand key regulatory bodies and concepts governing clinical development in various global markets; and become familiar with the ICH and its legal requirements for global clinical development. Note: This course may be substituted in place of Clinical Trial Management in the CTM certificate.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5541. Pharmaceutical Packaging: Technology and Regulation. 3 Credit Hours.

This course focuses on the complexities of packaging for the pharmaceutical industry, covering commonly used packaging systems (bottle/blister packaging for Oral solids) as well as niche applications (such as sterile/parenteral, inhalation, and nasal systems). In addition to the container/closure systems, some of the packaging processing methods will be covered. A review of the applicable regulatory environment and the submission requirements for drug products will be included. The submission needs will be covered, with a focus on the needs of the newly implemented Common Technical Document (CTD). A visit to a manufacturing facility of one of the industry's suppliers will be required.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5543. Good Distribution Practices. 3 Credit Hours.

Students will study the organizational, managerial and technology issues related to the supply chain, logistics, and distribution functions of the pharmaceutical industry, particularly generic pharmaceuticals.  They will be introduced to the tools and technologies that companies use to optimize their supply chain, logistics, and distribution functions, with specific emphasis on how generic companies configure and operate these aspects. Topics include: supply chain operations; integration with distributors, wholesalers, and other channels; WHO/FDA regulations and guidelines; supply chain security (counterfeiting, RFIDs, etc.); inventory considerations (management, turns, cost); demand and capacity planning; lean operations; postponement; supply constraints; and technologies.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5544. Regulatory Intelligence. 3 Credit Hours.

This course examines the fundamentals of Regulatory Intelligence, including what it is, how it is conducted, and how it is used to influence regulatory decision making throughout the development and lifecycle management of a therapeutic product. Students will learn to monitor the legislative and regulatory landscape by assessing accessible information data.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits

Pre-requisites:
(QARA 5459|Minimum Grade of B-|May not be taken concurrently
AND QARA 5592|Minimum Grade of B-|May not be taken concurrently).

QARA 5545. Post Approval Changes (PAC). 3 Credit Hours.

This course reviews SUPAC guidelines developed by CDER to maintain product safety, efficacy, and quality while giving manufacturers substantial regulatory relief and flexibility. A basic review of formulation development of various dosage forms provides a complete understanding of the guidelines and of regulatory strategies for formulation development.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5546. Global Pharmaceutical Excipient Regulation. 3 Credit Hours.

An integral part of almost all pharmaceutical dosage forms, excipients play an important role in drug development. This course discusses the function of excipients, providing an in-depth examination of their unique yet globally diverse regulatory requirements in major world markets. Excipient selection, assessment, and supplier qualifications will be discussed, as well as Adverse Events (AEs) related to excipient quality. This course stresses how global pharmaceutical excipient regulation is critical in developing formulations that have the potential for international approvals.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5547. Project Management for Clinical Trials. 3 Credit Hours.

Creation of clinical development plans to better lead, manage and operate clinical trials. Combines basic project management methodology and drug development best practices needed for leading and managing a clinical trial time.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits

Pre-requisites:
QARA 5459|Minimum Grade of B|May not be taken concurrently
OR QARA 5536|Minimum Grade of B|May not be taken concurrently.

QARA 5548. Risk Management of Pharmaceutical and Medical Devices. 3 Credit Hours.

This course focuses on risk management requirements and practices in the pharmaceutical, medical device, and biotech industries. Current regulations and risk management tools will be discussed and utilized to provide students with experience in executing risk assessments.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5571. Post-Marketing Safety Surveillance. 3 Credit Hours.

This course provides an in-depth understanding of post-marketing safety surveillance (PMSS) in the context of both American (FDA) and international (ICH-E2C) regulatory requirements. It begins with a historical overview of PMSS and then reviews the role of epidemiological methods in identifying signals and quantifying, assessing, and preventing adverse drug reactions (ADR). Medical/legal issues, benefits and limitations of safety surveillance systems, labeling changes, the ability to refute false signals, and social and ethical obligations inherent in the conduct of PMSS are discussed.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5572. Vaccines: Regulatory Affairs and Quality Assurance Issues. 3 Credit Hours.

This course addresses the history, research and development, manufacture, marketing, and medical impact of vaccines. Various public policy, regulatory, ethical, and legal issues in this area are discussed as they pertain to the U.S. and, to some extent, international markets. Beginning with the eradication of smallpox, this course covers the development of widely used vaccines against once common diseases (e.g., polio, mumps, varicella, etc.), to the development of vaccines against HIV, anthrax, and certain types of cancer.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5573. Pharmacoepidemiology. 3 Credit Hours.

This course introduces students to principles of study design, concepts of causal inference, and major types of epidemiological studies. These principles are applied to the distribution and determination of the effects (expected and unintended, beneficial and adverse) of pharmaceuticals on human populations. Risk-benefit analyses, cost-benefit assessments, regulatory issues, and legal and public health concerns are discussed.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5574. Pharmaceutical Quality Management Systems. 3 Credit Hours.

This course presents a comprehensive Quality Management Systems approach to the pharmaceutical industry based on Q10 regulations. SOPs, Deviation/Non-conformance, Corrective and Preventative Action, Supplier Management, Change Management, Validation, and Process controls via Key Performance Indicators are explored. Focus is placed on the key areas for inspection readiness and robust Quality Systems development.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may be repeated for additional credit..

QARA 5575. Regulatory Sciences: Managing the Guidelines to Quality. 3 Credit Hours.

The International Conference on Harmonization (ICH) has revolutionized the format and content of global regulatory filings with the Common Technical Document (CTD). Recent FDA draft guidelines have incorporated and expanded upon concepts described by the ICH. As the term "guideline" implies, such documents should not be generally viewed as regulations, but as "recommendations" to consider when developing the body of scientific information. Proper interpretation of the guidelines based on sound scientific principles is essential to optimize both the quality and quantity of information submitted to global regulatory agencies. Consequently, review of various ICH and FDA Quality guidelines will be supplemented by a discussion of the basic scientific principles that may influence implementation. After completing this course, students should understand the basic expectations set forth in various ICH and FDA Quality Guidelines. They should also realize that the guidelines are subject to interpretation and not definitive regulations.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5576. Global CMC Issues and Regulatory Dossier. 3 Credit Hours.

The course provides students with an in-depth knowledge of the major chemistry, manufacturing. and controls (CMC) issues facing the global pharmaceutical industry. Students learn the practical and theoretical skills necessary to develop successful CMC dossiers from the initial clinical application through marketing and post-marketing support. The class emphasizes long range CMC planning to combine technical and regulatory knowledge with strategic thinking. The class is designed for regulatory professionals, managers, and scientists with significant responsibility for CMC dossiers.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5577. Global CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics. 3 Credit Hours.

This course provides an introduction to the chemistry, manufacturing and controls (CMC) topics involved in the development and licensure of biologic products (biopharmaceuticals, vaccines) in the US, Europe and other highly regulated world regions. Topics will be discussed from the perspective of Regulatory and QA requirements and expectations. Basic microbiology, cell biology and chemistry concepts will be reviewed with an emphasis on their practical application to product development and RA/QA. The class orients RA/QA professionals, managers and scientists responsible for biopharmaceutical CMC development and preparation of dossiers to the CMC content matter and technical issues that must be addressed in biologic product development and registration globally. Topics include adventitious agents testing, cell and seed bank testing methods and requirements, drug substance production via cell culture, protein and virus purification methods, control and analysis of process impurities, analytical methods and potency testing for characterization and release, strategy for specification setting for release and stability, comparability studies for biologics.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits

Pre-requisites:
QARA 5459|Minimum Grade of B|May not be taken concurrently.

QARA 5578. Benefit Risk Management and Safety Signaling of Healthcare Products. 3 Credit Hours.

This course provides students with a basic understanding of the principles involved in developing, negotiating, and implementing Benefit-Risk Management Plans.  While the focus will be on risk management plans intended for the EU and USA markets, the general principles are applicable across most regulatory jurisdictions in the world.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits

Pre-requisites:
QARA 5571|Minimum Grade of B-|May not be taken concurrently
OR QARA 5538|Minimum Grade of B-|May not be taken concurrently.

QARA 5579. Regulatory and Legal Basis of Pharmacovigilance. 3 Credit Hours.

This course provides students with a basic understanding of the key regulations and laws that influence the development and management of a pharmacovigilance system, either in a manufacturer or health agency environments. The main emphasis will be on FDA, EU, and Japan and ICH, but discussions of emerging countries' systems will also be included. In addition to pharmaceuticals, the course provides an overview of the related product vigilance areas, such as medical devices, over-the-counter products, and drug/device combinations. In addition to understanding the regulatory framework, additional instruction will include discussions of partnership agreements, pharmacovigilance aspects of due diligence, licensing and acquisitions, and product liability issues.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5591. Global Regulatory Affairs. 3 Credit Hours.

This course provides a detailed analysis of the regulatory processes for new drug approvals outside of North America. Students gain experience in comparing the European and Japanese registration trends with those of the United States. Future regulatory structures in the major world markets are explored.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5592. Food and Drug Law. 3 Credit Hours.

This course studies the governance of intra- and interstate commerce in foods, drugs, cosmetics, and medical devices and the effects of the Federal Food, Drug and Cosmetic Act upon research, manufacture, marketing, and distribution of drugs. Note: This course is required for the M.S. in RA and QA and for the Drug Development Certificate.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5594. Regulation of Dietary Supplements, Botanicals, and Nutraceuticals. 3 Credit Hours.

The course focuses on legal issues surrounding the regulation of dietary supplements, nutraceuticals, and botanicals. When does a dietary supplement become a drug under the Federal Food, Drug and Cosmetic Act? What are the legal requirements for labeling? How are claims treated? These topics, along with current issues related to the regulations of dietary supplement are explored. The impact of the Dietary Supplement Health and Education Act, the Federal Food, Drug and Cosmetic Act, the FDA Modernization Act (FDAMA), and other relevant laws are examined. The enforcement authority of other federal regulatory agencies, that is, the FDA and the Federal Trade Commission, is detailed.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5595. Food Law. 3 Credit Hours.

While Food and Drug Law I (Pharmaceutics 5592) briefly touches on food law, this course examines the major federal statutes and regulations applicable to food in more detail. While emphasis is placed on the role, policies, and regulations of the U.S. FDA, the practical working relationships and obligations between the food industry, the USDA, and other government entities at the state and local level are also examined. Recent efforts to respond to and combat foodborne illnesses are discussed, along with reporting requirements and recalls of defective or injurious products and micro-contamination. The course examines the quality practices respected and utilized by the FDA and USDA in the regulation of the global food supply. The Food Safety and Modernization Act is explained, including the FDA's and USDA's continuing obligations in implementation of this landmark legislation. Also presented are pertinent landmark judicial decisions and concepts relating to interstate commerce, corporate and individual responsibility, labeling and promotion, and importation/exportation of products that have direct applicability towards the regulation of medical products in addition to food. The practicum exposes students to FDA's Form 483, which is the usual mode of conveying objectionable conditions for correction.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5596. Food Labeling and Regulatory Affairs. 3 Credit Hours.

Students are provided with an in-depth understanding about how food in the U.S. must be labeled regardless of its country of origin. It examines the roles and procedures of the principal regulators (U.S. FDA and the U.S. Department of Agriculture) and their interaction with the regulated industry and third party peripherals, including consultants and analyzing laboratories. Students will learn about the food label and all of its components, problems associated with incorrect or deceptive labeling, including the risks to consumers and food manufacturers, marketers and sellers. The course introduces regulatory intelligence identifiers, including the generation of press releases and notifications when recalls are warranted. Finally the impact of recent or impending legislation or regulations for food businesses regulated by the FDA (including and especially the Food Safety and Modernization Act) will be discussed. Students will learn to identify the critical components of a food product's label, gain knowledge of the laws and regulations governing food labeling, and understand the intricacies of recalls and market withdrawals.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits

Pre-requisites:
QARA 5592|Minimum Grade of B-|May not be taken concurrently
OR QARA 5595|Minimum Grade of B-|May not be taken concurrently.

QARA 5597. Food Good Manufacturing Processes. 3 Credit Hours.

This course covers cGMPs (current Good Manufacturing Practices) for human food. Food safety regulations under the Food, Drug, and Cosmetic Act are covered as well as their impact on personnel, facilities, equipment, and production. Emphasis is placed on preventing foodborne hazards via an understanding of food microbiology, pathogen control, sanitation measures, allergen control, low acid canning, acidification, HACCP, and preventive controls.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5599. Clinical Aspects of Pharmaceutical Medicine. 3 Credit Hours.

This course offers students a basic understanding of the disease processes most prevalent in Western culture. Students gain an appreciation for the epidemiology and demographic patterns of disease and their societal and economic impact. In addition, students gain a basic understanding of the etiology and the pathophysiology underlying the disease processes and the role of pharmacologic intervention.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5601. Industry Interactions with FDA/Health Authorities. 3 Credit Hours.

Presenting a global perspective by reviewing the drug approval process in the European Union (EU), this course introduces students to the importance of establishing liaisons with officials with the U.S. FDA and other world health authorities. The rapport developed with health authorities frequently lessens the time it takes to get a new drug to market. How a firm presents its data can contribute as much to the successful relationship with health authorities as the quality of data presented. Areas include: FDA organization, average workload analysis with FDA, FDA review and drug approval process, national versus mutual recognition versus centralized approval process in the EU, user fees, company "personalities," FDA/Industry meetings, inspections, Advisory Committees, IND/NDA classification system, FDA initiatives to speed drug approval including electronic submissions, and notable internet regulatory addresses.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5602. Clinical Aspects of Pharmaceutical Medicine II. 3 Credit Hours.

Students study key areas of clinical medicine and scientific topics such as genetics, gastroenterology, obstetrics and gynecology, medical ethics, hepatology, and emergency medicine. This course includes new issues and updates in specialties such as cardiology and oncology.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5605. Advanced Topics in Food and Drug Law. 3 Credit Hours.

This course expands the regulatory concepts covered in QARA 5592. Each semester the specific topics change.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5611. Regulation of Advertising and Promotions. 3 Credit Hours.

This course reviews the regulatory and legal fundamentals of advertising and promotion of FDA-regulated prescription products. Emphasis will be placed on prescription pharmaceuticals and the current regulatory and legal environment. Discussions include how prescription drug regulations differ from those applicable to OTCs (over-the-counter drugs), biologics and restricted medical devices.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits

Pre-requisites:
QARA 5533|Minimum Grade of B-|May not be taken concurrently.

QARA 5612. Bioethics for Pharmaceutical Professionals. 3 Credit Hours.

This course focuses on bioethical issues arising in the regulation and conduct of research. It instills a basic understanding of bioethics and the theories and principles underlying its practices and application to research. It also discusses how bioethical theories and principles provide the foundation for many research regulations. Starting with a brief history of research ethics and regulation, it explores past and present ethical research controversies. Note: This course is required for the Certificate in Clinical Trial Management.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5615. Project Management for Pharmaceutical Professionals. 3 Credit Hours.

This course discusses the strategic positioning of drugs, specifically focusing on domestic and international registration strategies. It explores why a company seeks a particular indication in labeling and how RA/QA professionals play a critical role in understanding and developing regulatory intelligences. It covers how project teams should be created, including the effective clarification of roles and responsibilities, so regulatory timeliness can be achieved. Workshops include an overview of project planning tools, techniques and critical path management, including negotiating registration strategies with the FDA and foreign agencies.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5618. Clinical Data Management (CDM). 3 Credit Hours.

Data management is the activity of collecting, reviewing, organizing, and analyzing data from clinical research studies. The data from clinical research studies are the crux of a regulatory submission for a new drug or biologic. There is no basis for a therapeutic claim without data. Thus the success of a submission depends on quality data management practices and strict adherence to regulatory requirements. This course teaches students how to go from collecting data for the first protocol to ultimate submission to a regulatory agency from data collection, management, and reporting perspectives. Note: This course is required for the Certificate in Clinical Trial Management.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5621. Regulatory Bioanalysis. 3 Credit Hours.

This course covers several broad topics: (1) a high-level quantitative analysis of biological samples that provide date to support pharmaceutical drug/biological product approval, (2) detailed instruction of FDA and EMA regulations and guidances that govern bioanalytical method development, validation and application in routine sample analysis, (3) "best practices" recommended for implementing quality management systems in a bioanalytical laboratory, and (4) discussion of approaches to address common problems that may arise during method validation and sample analysis.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5622. Unit Operations. 3 Credit Hours.

This course will expose students to the current process steps common to the manufacture of modern pharmaceuticals.  In particular, the key variables for each step of a process will be discussed. Each class will feature a specific process common to pharmaceutical processing.  Specific variables will be discussed, including an analysis of each process. At the end of the course the student should be able to describe a process by a series of smaller operations, describe the key variables for each small operation, identify key limitations of time and resources in proposed processes, and provide constructive improvements to complex processes.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5625. Process Analytical Technology (PAT). 3 Credit Hours.

The course focuses on state-of-the art utilization of process controls, including multivariate methods and feed-back loops.  It will investigate analytical tools, including thermal conductivity, NIR, and Raman spectroscopy.  It will also cover process analysis and feedback, as well as batch record analysis.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5627. Statistical Design of Experiments (DOE). 3 Credit Hours.

This course exposes students to the use of statistical methods for designing optimal processes used in industry, extensively using data sets and data charting.  At the end of the course the student should be able to: create an experimental plan to optimize a process; create a screening study to limit the number of experiments; use surface methodology to set process specifications; and use specialized methodology for material analysis.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5629. Process Monitoring. 3 Credit Hours.

This course reviews Control Charting, Six Sigma, Root Cause Analysis, Risk/Benefit Analysis, Process Capability, and Process Efficiency/Lean Manufacturing.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 5650. Special Topics in Regulatory Affairs and Quality Assurance. 3 Credit Hours.

Special topics as announced.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may be repeated for additional credit..

QARA 5655. Analytical Chemistry in Pharmaceutical Laboratories. 3 Credit Hours.

This course provides an overview of laboratory operations and the critical role of an analytical scientist. It reviews regulatory requirements for pharmaceutical lab operations and provides a framework for quality in a drug development laboratory. Although the course is designed for pharmaceutical scientists, many of the operations discussed are applicable to the chemical and environmental industries.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 8001. Principles of Drug Action/PK. 3 Credit Hours.

This course presents the fundamental principles of pharmacology, medicinal chemistry, and pharmacokinetics needed to understand their application in drug discovery and developmental processes.  The material, presented in an integrated manner, includes the molecular mechanisms of drug action, structure-activity relationships, and the time-course of drug absorption and disposition.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 8002. Pharmaceutical Analysis. 3 Credit Hours.

Application of chemical analysis as it relates to pharmaceuticals and pharmaceutical manufacturing. Classical separation methods including GC and HPLC, as well as hyphenated techniques (GS-MC and HPLC-MC) will be explored. Students will also be introduced to newer immunologic antibody-based procedures and emerging technologies.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 8003. Pharmaceutical Manufacturing I: Preformulation/Formulation. 3 Credit Hours.

This course covers advances made in understanding powder behavior and many useful qualitative and quantitative measurements of factors important to industrial pharmacy and product development.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 8004. Pharmaceutical Manufacturing II: Solid Dosage Forms. 3 Credit Hours.

This course presents the comprehensive, integrated, and most up-to-date methods, processing, and principles as they apply to solid dosage form design and product development. Conventional and specific techniques of industrial pharmacy, including direct compression, wet and dry granulation, fluid bed and coating operations, tableting machine instrumentation and compatibility measurements, and solid product evaluation will be presented. Novel oral dosage forms and technologies associated with solid products as well as product quality and performance assessment will be covered.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 8006. Physical Pharmacy I. 3 Credit Hours.

The emphasis of this course is to form a bridge between the concepts of physical pharmacy and the application of pharmaceutical sciences. Students will understand basic aspects of intermolecular forces, physical properties of solutions, ionic equilibria, buffers and isotonic solutions, solubility and partition phenomena, complexation and protein binding, reaction kinetics, mass transport, dissolution phenomena, interfacial phenomena, and rheology. Pharmaceutical applications based on the basic principles will be discussed as well. Students will be expected to be able to apply the basic concepts from this course to typical formulation and stability issues of pharmaceutical dosage forms.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

QARA 8007. Applied Biopharmaceutics. 3 Credit Hours.

This course considers the interrelationship of the physicochemical properties of the drug, the dosage form, and the route of administration on the rate and extent of systemic drug absorption. Drug absorption mechanisms, physiological and GIT constraints on dosage form transit and bioavailbility, effect of formulation parameters, dissolution methodologies, in-vitro/in-vivo correlation of drug product performance as well as PAC, ICH and FDA guidelines on development and approval process will be covered. Formulation strategies for optimum therapeutic outcome via application of pharmaceutical sciences to the design of drug delivery systems is provided.

Level Registration Restrictions: Must be enrolled in one of the following Levels: Graduate

Repeatability: This course may not be repeated for additional credits.

Contacts

Certificate Program Web Address:

http://www.temple.edu/pharmacy_qara/certificates.htm

Department Information:

Regulatory Affairs and Quality Assurance Graduate Program

425 Commerce Drive, Suite 175

Fort Washington, PA 19034-2713

qara@temple.edu

267-468-8560

Mailing Address for Application Materials:

Regulatory Affairs and Quality Assurance Graduate Program

425 Commerce Drive, Suite 175

Fort Washington, PA 19034-2713

Department Contacts:

Admissions:

Wendy Lebing, MALD, M.S.

Program Coordinator

qara@temple.edu

267-468-8560